After this afternoon's 1.7% surge to $527.46 per share, Thermo Fisher Scientific might just keep moving past its target price of $542.53. With an average analyst rating of buy, and target prices from $435.0 to $640.0, the stock's next move is anyone's guess.
Thermo Fisher Scientific's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.6%. The stock's short ratio is 1.34. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 91.2%. In conclusion, we believe there is mixed market sentiment regarding Thermo Fisher Scientific.
Institutions Invested in Thermo Fisher Scientific
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-09-30 | Vanguard Group Inc | 8% | 32,760,738 | $17,279,815,621 |
| 2023-09-30 | Blackrock Inc. | 7% | 27,995,969 | $14,766,614,307 |
| 2023-09-30 | State Street Corporation | 4% | 15,641,589 | $8,250,234,593 |
| 2023-09-30 | Capital World Investors | 3% | 12,755,007 | $6,727,692,435 |
| 2023-09-30 | Morgan Stanley | 3% | 12,418,429 | $6,550,162,680 |
| 2023-09-30 | Price (T.Rowe) Associates Inc | 3% | 10,138,105 | $5,347,394,346 |
| 2023-09-30 | FMR, LLC | 2% | 8,320,024 | $4,388,438,401 |
| 2023-09-30 | Capital Research Global Investors | 2% | 7,472,477 | $3,941,395,483 |
| 2023-09-30 | Geode Capital Management, LLC | 2% | 7,118,339 | $3,754,603,618 |
| 2023-09-30 | Massachusetts Financial Services Co. | 2% | 6,407,061 | $3,379,436,469 |
